RT Conference Proceedings
T1 IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS
A1 Lopez-Pedrera, C.
A1 Munoz-Barrera, L.
A1 Escudero Contreras, A.
A1 Aguirre-Zamorano, M. A.
A1 Ortiz Buitrago, P.
A1 Lopez-Medina, C.
A1 Calvo Gutierrez, J.
A1 Ortega Castro, R.
A1 Pilar, F. U.
A1 Sanchez-Pareja, I.
A1 Abalos-Aguilera, M. C.
A1 Barbarroja Puerto, N.
A1 Collantes Estevez, E.
A1 Perez-Sanchez, C.
K1 Arthritis, rheumatoid
K1 Lupus erythematosus, systemic
K1 Reverse transcriptase polymerase chain reaction
K1 Correlation of data
AB Background: Systemic autoimmune diseases such as Rheumatoid Arthritis(RA) and Systemic Lupus Erythematosus (SLE) are characterised by aberrantautoimmune and inflammatory processes, which are directly associated with the development and progression of these disorders. Novel biomarkers associated with the severity of these diseases are needed to better characterise and monitor their progression as well as to develop new and more effective therapeutic strategies.
PB BMJ Group
SN 0003-4967
YR 2022
FD 2022-06-01
LK http://hdl.handle.net/10668/20121
UL http://hdl.handle.net/10668/20121
LA en
NO Lopez-Pedrera C, Muñoz-Barrera L, Contreras AE, Aguirre-Zamorano MÁ, Buitrago PO, López-Medina C, et al. POS0058 IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):245.2-245
DS RISalud
RD Apr 8, 2025